Clinical trials: Anxiety, Generalized
Anxiety Disorder
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
This is a clinical trial assessing duloxetine and comparator to placebo in patients who have generalized anxiety disorder.
- Trial name
- NCT00122837
- Testing
- Duloxetine, venlafaxine
- Where
- 22 sites in Argentina, Australia and 6 more
- Volunteers
- 560 people
- Sponsor
- Eli Lilly and Company
Generalized Anxiety Disorder
Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials
Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics.
- Trial name
- NCT06254157
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Generalized Anxiety Disorder
Comparing Different CBT Approaches in GAD
Cognitive-behavior therapy (CBT) is considered the "golden standard" psychotherapy for generalized anxiety disorder (GAD). However, it entails different approaches and blanket statements remain hard to formulate.
- Trial name
- CBTforGAD (NCT03650465)
- Testing
- Cognitive-behavioral therapy (CBT)
- Where
- Romania
- Volunteers
- 75 people
- Sponsor
- Babes-Bolyai University
Recurrent Pregnancy Loss(RPL), Anxiety
High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety
The goal of this clinical trial is to determine whether high-intensity, low-frequency periodic repetitive transcranial magnetic stimulation (rTMS) applied to the right dorsolateral prefrontal cortex (DLPFC) can modulate cardiac…
- Trial name
- NCT07233278
- Testing
- Rhythmic repetitive transcranial magnetic stimulation (rTMS) at 120% RMT, 1 Hz, 60-s cycles
- Where
- 3 sites in China
- Volunteers
- 48 people
- Sponsor
- Shenyang Medical College
Major Depressive Disorder, Generalized Anxiety Disorder
Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
The primary objective is to test the hypothesis that quetiapine XR (Extended Release) monotherapy or adjunctive therapy to antidepressant is superior to placebo monotherapy or placebo adjunctive therapy to antidepressant(s) in…
- Trial name
- MDD/GAD (NCT00868374)
- Testing
- Quetiapine XR
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- Keming Gao
Major Depressive Disorder Co-Occurrent With Anxiety, Adult Patients
First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic
According to the local guidelines (Recommendation for General Practitioners), the first choice Anti-Depressant (AD) in Major Depressive Disorder (MDD) in primary care should be selective serotonin reuptake inhibitors (SSRI), e.g.
- Conditions
- Major Depressive Disorder Co-Occurrent With Anxiety, Adult Patients, Newly Diagnosed Depression
- Trial name
- FIAT (NCT05291897)
- Where
- 6 sites in Czechia
- Volunteers
- 28 people
- Sponsor
- Angelini Pharma Česká republika s.r.o.
Anxiety Disorders
A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
The study will look at the effect of MK0777on reducing anxiety in subjects with general anxiety disorder. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time.
- Trial name
- NCT00543920
- Testing
- MK0777
- Volunteers
- 60 people
- Sponsor
- Merck Sharp & Dohme LLC
Generalized Anxiety Disorder
A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder
Sensoril - Extracts of Withania somnifera (Ashwagandha in Ayurvedic Medicine) have shown potent anti-stress, cortisol lowering, GABAergic, serotonergic and antioxidant properties in animal and human studies.
- Trial name
- NCT01311180
- Testing
- Sensoril®
- Where
- 7 sites in India
- Volunteers
- 120 people
- Sponsor
- Natreon, Inc.
Stress, Psychological, Stress, Emotional
Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19
A new pandemic appeared in early 2020, also known as the coronavirus (Covid-19), affecting all health systems worldwide. Medical and nursing staff make every effort to treat patients resulting in physical and psychological…
- Conditions
- Stress, Psychological, Stress, Emotional, Life Style Induced Illness, Anxiety Depression
- Trial name
- NCT04791085
- Where
- Greece
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- National and Kapodistrian University of Athens
Generalized Anxiety Disorder
Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
The goals of this pilot study are as follows: 1) To disseminate and examine the effectiveness of a manualized, individual, cognitive-behavioral psychotherapy (CBT) for adults with Generalized Anxiety Disorder(GAD), 2) to test the…
- Trial name
- NCT00219349
- Testing
- Cognitive Behavioral Therapy, escitalopram
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- New York State Psychiatric Institute
Anxiety Disorder, Generalized Anxiety Disorder
Electroclinical Correlation of Anxiety
Anxiety disorders have the highest prevalence among mental disorders and cause considerable individual and financial costs. Current treatments do not relieve mental suffering of many patients.
- Conditions
- Anxiety Disorder, Generalized Anxiety Disorder, Drug Resistant Epilepsy
- Trial name
- IRAnxNet (NCT05393518)
- Testing
- Anxiety-induced task, Neuropsychiatric assessment
- Where
- France
- Volunteers
- 30 people
- Sponsor
- University Hospital, Bordeaux
Generalized Anxiety Disorder, Menopause
Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety
This study will determine the effectiveness of the herb black cohosh for treating menopause-related anxiety symptoms in women. Study hypotheses: 1) Black cohosh will have a superior anti-anxiety effect compared to placebo.
- Trial name
- NCT00120458
- Testing
- Black cohosh
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Pennsylvania
Generalized Anxiety, Social Phobia
Project Collabri for Treatment of Anxiety
The purpose of this study is to determine whether treatment of patients with anxiety according to the Collabri Model is more effective in reducing symptoms compared to treatment as usual (TAU)
- Conditions
- Generalized Anxiety, Social Phobia, Panic Disorder
- Trial name
- NCT02678624
- Testing
- Treatment according to the Collabri model
- Where
- Denmark
- Volunteers
- 406 people
- Sponsor
- Amager Hospital
Generalized Anxiety Disorder
Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder
The study will evaluate the long-term maintenance of efficacy of Lu AA21004 in patients with Generalized Anxiety Disorder (GAD) who responded to acute treatment with Lu AA21004.
- Trial name
- NCT00788034
- Testing
- Lu AA21004
- Where
- 81 sites in Argentina, Chile and 9 more
- Volunteers
- 459 people
- Sponsor
- H. Lundbeck A/S
Posttraumatic Stress Disorder, Major Depressive Disorder
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
Public safety personnel (PSP; e.g., border services personnel, correctional workers, firefighters, paramedics, police, public safety communicators) are frequently exposed to potentially psychologically traumatic events.
- Conditions
- Posttraumatic Stress Disorder, Major Depressive Disorder, Panic Disorder, Generalized Anxiety Disorder
- Trial name
- NCT05530642
- Testing
- Emotional Resilience Skills Training (ERST)
- Where
- Canada
- Volunteers
- 192 people, healthy volunteers welcome
- Sponsor
- University of Regina
Parkinson's Disease, Generalized Anxiety Disorder
Cognitive Behavioural Therapy for Anxiety Disorders in PD
Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have a negative effect on gait, dyskinesia, freezing, on/off fluctuations, and quality of life.
- Conditions
- Parkinson's Disease, Generalized Anxiety Disorder, Social Phobia
- Trial name
- NCT02648737
- Testing
- Cognitive Behavioural Therapy (CBT), Clinical monitoring
- Where
- 2 sites in France, Netherlands
- Volunteers
- 50 people
- Sponsor
- Maastricht University Medical Center
Major Depressive Disorder, Generalized Anxiety Disorder
Cohort Study on Medical Students' Mental Health
The main objective of this study is to identify risk factors for depression among medical students by comparing them to students who completed their first year but did not enter the medical program (students not accepted into the…
- Conditions
- Major Depressive Disorder, Generalized Anxiety Disorder, Suicidal Ideation, Alcoholism
- Trial name
- OSMOSE (NCT07305701)
- Testing
- Questionnaire
- Where
- France
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Régional d'Orléans
Analogue Generalized Anxiety Disorder
The Resistance Exercise Training for Worry Trial: Replication and Expansion
This protocol details the full methods of a ten-week moderate-to-high intensity, guidelines-based resistance exercise training intervention compared to a low intensity sham attention control among young adult women with analogue…
- Trial name
- RETRAIN REP-EX (NCT06804629)
- Testing
- Moderate-to-High Intensity Resistance Exercise Training
- Where
- Ireland
- Volunteers
- 68 people
- Sponsor
- University of Limerick
Generalized Anxiety Disorder (GAD), Healthy Participants
Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants
The main objective of this study is to assess pharmacokinetics, safety, and tolerability of ABBV-932 in healthy adult participants.
- Trial name
- NCT05738850
- Testing
- ABBV-932
- Where
- 2 sites in United States
- Volunteers
- 104 people, healthy volunteers welcome
- Sponsor
- AbbVie
MDD, Anxiety Disorders
Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
This study evaluates the effectiveness of vortioxetine on depressive symptoms in patients with depression coexisting with generalized anxiety disorder.
- Trial name
- RECONNECT (NCT04220996)
- Testing
- Vortioxetine
- Where
- 21 sites in Estonia, France and 4 more
- Volunteers
- 100 people
- Sponsor
- H. Lundbeck A/S